Rosemont Drug Patent Portfolio

Rosemont owns 2 orange book drugs protected by 2 US patents Given below is the list of Rosemont's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12390439 Oral Liquid Formulation Of Methocarbamol 09 Oct, 2044
Active
US12343338 Ramipril Solution For Oral Dosage 16 Aug, 2039
Active


Given below is the list of recent legal activities going on the following drug patents of Rosemont.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 26 Aug, 2025 US12390439
Patent Issue Date Used in PTA Calculation 19 Aug, 2025 US12390439
Mail Patent eGrant Notification 19 Aug, 2025 US12390439
Email Notification 19 Aug, 2025 US12390439
Recordation of Patent eGrant 19 Aug, 2025 US12390439
Patent eGrant Notification 19 Aug, 2025 US12390439
Email Notification 07 Aug, 2025 US12390439
Issue Notification Mailed 06 Aug, 2025 US12390439
Application Is Considered Ready for Issue 25 Jul, 2025 US12390439
Dispatch to FDC 25 Jul, 2025 US12390439
Issue Fee Payment Received 22 Jul, 2025 US12390439
Issue Fee Payment Verified 22 Jul, 2025 US12390439
Mail Notice of Allowance 21 Jul, 2025 US12390439
Notice of Allowance Data Verification Completed 17 Jul, 2025 US12390439
Recordation of Patent Grant Mailed 08 Jul, 2025 US12343338


Rosemont's Family Patents


Family Patents



Rosemont Drug List

Given below is the complete list of Rosemont's drugs and the patents protecting them.


1. Atmeksi

Atmeksi is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12390439 Oral Liquid Formulation Of Methocarbamol 09 Oct, 2044
(18 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atmeksi's drug page


2. Vostally

Vostally is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12343338 Ramipril Solution For Oral Dosage 16 Aug, 2039
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vostally's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List